Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ALDX Insider Trading

Aldeyra Therapeutics, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Aldeyra Therapeutics, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-03-20 20:17 2026-03-19 DOUGLAS RICHARD Director BUY $1.40 70,000 $98,000 195,000 +56.0%
2026-03-19 21:29 2026-03-18 Alfieri Michael Officer - Principal Financial Officer BUY $1.42 5,000 $7,100 7,500 +200.0%
2025-08-15 23:09 2025-08-13 Alfieri Michael Officer - Principal Financial Officer BUY $5.30 2,500 $13,250 2,500 +100.0%
2025-08-14 01:03 2025-08-11 Machatha Stephen Officer - Chief Development Officer SELL $5.15 22,073 $113,713 221,799 -9.1%
2025-04-08 01:43 2025-04-03 PERCEPTIVE ADVISORS LLC 10% owner SELL $1.42 3,400,000 $4,828,000 5,875,851 -36.7%
2024-10-22 03:22 2021-05-03 Miller-Rich Nancy Director BUY $11.33 922 $10,447 922 +100.0%
2024-08-14 23:24 2024-08-12 Machatha Stephen Officer - Chief Development Officer SELL $4.74 16,041 $75,975 236,771 -6.3%
2024-08-14 23:24 2024-08-12 Greenberg Bruce Officer - See Remarks SELL $4.74 10,834 $51,313 126,382 -7.9%
2024-04-17 23:12 2024-03-12 Machatha Stephen Officer - Chief Development Officer SELL $3.16 11,537 $36,503 252,812 -4.4%
2024-04-17 23:10 2024-03-11 Greenberg Bruce Officer - See Remarks SELL $3.41 13,201 $44,968 130,154 -9.2%
2024-04-09 00:32 2024-04-04 PERCEPTIVE ADVISORS LLC 10% owner BUY $4.68 177,993 $833,862 9,275,851 +2.0%
2024-04-04 00:22 2024-04-01 PERCEPTIVE ADVISORS LLC 10% owner BUY $3.84 504,272 $1,934,488 9,097,858 +5.9%
2024-03-13 03:07 2024-03-11 Greenberg Bruce Officer - See Remarks SELL $3.41 13,201 $44,968 120,699 -9.9%
2024-03-13 03:04 2024-03-11 Machatha Stephen Officer - Chief Development Officer SELL $3.31 29,768 $98,607 243,495 -10.9%
2024-03-13 03:01 2024-03-11 Brady Todd C Director, Officer - President and CEO SELL $3.17 183,238 $580,755 1,471,298 -11.1%
2023-10-19 00:15 2023-10-16 PERCEPTIVE ADVISORS LLC 10% owner SELL $1.62 2,756,499 $4,453,400 8,593,586 -24.3%
2022-08-11 23:08 2022-08-09 PERCEPTIVE ADVISORS LLC 10% owner BUY $7.55 115,000 $867,756 11,350,085 +1.0%
2022-08-10 23:10 2022-08-08 PERCEPTIVE ADVISORS LLC 10% owner BUY $7.24 97,000 $702,280 11,235,085 +0.9%
2022-08-09 23:08 2022-08-05 PERCEPTIVE ADVISORS LLC 10% owner BUY $6.95 141,000 $979,950 11,138,085 +1.3%
2022-08-08 23:09 2022-08-04 PERCEPTIVE ADVISORS LLC 10% owner BUY $6.17 95,100 $586,767 10,997,085 +0.9%
2022-08-05 23:10 2022-08-03 PERCEPTIVE ADVISORS LLC 10% owner BUY $5.84 100,000 $584,000 10,901,985 +0.9%
2022-08-04 23:10 2022-08-02 PERCEPTIVE ADVISORS LLC 10% owner BUY $5.59 412,406 $2,305,350 10,801,985 +4.0%
2022-08-04 00:16 2022-08-01 PERCEPTIVE ADVISORS LLC 10% owner BUY $5.05 144,185 $728,134 10,389,579 +1.4%
2022-08-02 23:27 2022-07-29 PERCEPTIVE ADVISORS LLC 10% owner BUY $5.03 222,123 $1,117,279 10,245,394 +2.2%
2022-08-02 00:37 2022-07-28 PERCEPTIVE ADVISORS LLC 10% owner BUY $5.00 119,392 $596,960 10,023,271 +1.2%
2022-06-27 13:41 2022-06-23 Brady Todd C Director, Officer - President and CEO BUY $3.36 17,700 $59,546 1,216,535 +1.5%
2022-06-27 13:42 2022-06-23 JOYCE MARTIN JOSEPH Director BUY $3.48 4,323 $15,025 23,967 +22.0%
2021-05-05 00:55 2021-05-03 PERCEPTIVE ADVISORS LLC 10% owner BUY $12.50 1,200,000 $15,000,000 9,903,879 +13.8%
2021-01-22 01:24 2021-01-19 PERCEPTIVE ADVISORS LLC 10% owner BUY $9.50 1,368,421 $13,000,000 8,703,879 +18.7%
2021-01-12 05:53 2021-01-07 PERCEPTIVE ADVISORS LLC 10% owner BUY $8.76 1,050,000 $9,202,620 7,335,458 +16.7%
2020-07-13 23:30 2020-07-09 PERCEPTIVE ADVISORS LLC 10% owner BUY $4.25 3,200,000 $13,600,000 6,285,458 +103.7%
2020-03-17 23:38 2020-03-16 DOUGLAS RICHARD Director BUY $2.75 40,000 $110,000 125,000 +47.1%
2019-12-18 15:35 2019-12-16 Brady Todd C Director, Officer - President and CEO BUY $5.10 20,000 $101,908 652,216 +3.2%
2019-10-02 14:36 2019-09-30 Brady Todd C Director, Officer - President and CEO BUY $5.68 8,710 $49,483 632,216 +1.4%
2019-09-25 14:40 2019-09-23 Brady Todd C Director, Officer - President and CEO BUY $5.81 8,680 $50,433 623,506 +1.4%
2019-09-20 14:37 2019-09-18 Brady Todd C Director, Officer - President and CEO BUY $5.91 14,288 $84,465 614,826 +2.4%
2019-09-19 23:23 2019-09-17 Bronstein Ben Director BUY $5.85 1,700 $9,945 18,644 +10.0%
2019-09-17 14:35 2019-09-13 Brady Todd C Director, Officer - President and CEO BUY $5.85 13,000 $75,990 591,991 +2.2%
2019-09-17 23:21 2019-09-13 Brady Todd C Director, Officer - President and CEO BUY $5.91 21,547 $127,448 600,538 +3.7%
2019-09-17 14:36 2019-09-13 DOUGLAS RICHARD Director BUY $6.00 5,000 $30,000 85,000 +6.3%
2019-09-16 23:15 2019-09-12 JOYCE MARTIN JOSEPH Director BUY $5.86 1,700 $9,964 19,644 +9.5%
2019-09-13 14:54 2019-09-11 DOUGLAS RICHARD Director BUY $5.89 20,000 $117,804 80,000 +33.3%
2019-09-11 23:05 2019-09-09 Brady Todd C Director, Officer - President and CEO BUY $5.14 20,000 $102,824 578,991 +3.6%
2019-09-11 23:05 2019-09-09 DOUGLAS RICHARD Director BUY $5.00 20,000 $99,964 60,000 +50.0%
2019-09-11 00:01 2019-09-06 Clark David J Officer - Chief Medical Officer BUY $5.06 5,000 $25,311 17,878 +38.8%
2019-09-09 23:38 2019-09-05 Reed Joshua Officer - Chief Financial Officer BUY $4.71 3,200 $15,072 35,774 +9.8%
2019-09-09 23:37 2019-09-05 McMullin David Officer - Chief Commerical Officer BUY $4.68 4,329 $20,260 6,148 +238.0%
2019-03-29 00:10 2019-03-26 TREU JESSE I Director SELL $10.01 96,743 $968,397 8,763 -91.7%
2017-09-21 15:45 2017-09-19 PERCEPTIVE ADVISORS LLC 10% owner BUY $7.25 200,000 $1,450,000 3,085,458 +6.9%
2017-07-06 00:56 2017-06-30 PERCEPTIVE ADVISORS LLC 10% owner BUY $4.60 296,007 $1,361,632 2,885,458 +11.4%
SHOW ENTRIES

How to Interpret $ALDX Trades

Not every insider transaction in Aldeyra Therapeutics, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ALDX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ALDX

Insider activity data for Aldeyra Therapeutics, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ALDX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.